Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis (2020-2027)
Isothermal nucleic acid technologies have applications in the field of recombinant DNA and molecular biology techniques. These techniques are used in the detection and analysis of small quantity of nucleic acids. Polymerase chain reaction is based on isothermal nucleic acid amplification technology. The polymerase chain reaction (PCR) is most widely used method for DNA amplification. Polymerase chain reaction (PCR) is used for the detection and identification of infectious diseases, genetic disorders, and for research purposes. PCR consists of thermocycling machine, which facilitates separation and amplification of DNA strands.
Market Dynamics
Increasing approvals from healthcare regulatory authorities for innovative technologies is expected to drive the global isothermal nucleic acid amplification technology (INAAT) market growth
For instance, in October 2018, Abbott laboratories received the U.S. Food and Drug Administration (FDA) for its next-generation Influenza A & B2 and Strep A2 molecular assays. These assays are used for the molecular detection and differentiation of influenza A and B virus. Next-generation Influenza A & B2 and Strep A2 molecular assays are currently available on ID NOW platform, which is a rapid isothermal system. It is used for the detection of infectious diseases such as influenza.
Rising product launches by key players is expected to boost the global isothermal nucleic acid amplification technology (INAAT) market growth
For instance, in July 2017, TwistDx Inc. launched TwistAmp, a recombinase polymerase amplification (RPA) kit. It is used for DNA/RNA amplification. TwistAmp is an isothermal alternative to polymerase chain reaction PCR.
Key features of the study:
· This report provides in-depth analysis of the global isothermal nucleic acid amplification technology (INAAT) market size (US$ Mn), and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018 as the base year
· It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
· This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
· It profiles key players in the global isothermal nucleic acid amplification technology (INAAT) market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
· Key players covered as a part of this study include Alere Inc., Becton, Dickinson & Company, BioHelix Corporation, BioMerieux Biotechnology Company, Hologic Gene-Probe, QIAGEN Company, Thermo Fisher Scientific, Inc., Lucigen Corporation, Quidel Corporation, and NuGEN
· Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
· The global isothermal nucleic acid amplification technology (INAAT) market report caters to various stakeholders in this industry including investors, product manufacturers, distributors, and suppliers for isothermal nucleic acid amplification technology (INAAT) market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
· Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Product Type:
o Instruments
o Reagents & Kits
· Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Application:
o Infectious Disease Diagnostics
o Blood Screening
o Others
· Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By Technology:
o Helicase Dependent Amplification (HAD)
o Nicking Enzyme Amplification Reaction (NEAR)
o Nucleic Acid Sequence Based Amplification (NASBA)
o Transcription Medicated Amplification (TMA)
o Single Primer Isothermal Amplification (SPIA)
o Loop-mediated Isothermal Amplification (LAMP)
· Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market, By End User:
o Academic and Research Institutes
o Diagnostic Laboratories
o Others
· Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market , By Region:
o North America
§ By Product Type:
§ Instruments
§ Reagents & Kits
§ By Technology:
§ Helicase Dependent Amplification (HAD)
§ Nicking Enzyme Amplification Reaction (NEAR)
§ Nucleic Acid Sequence Based Amplification (NASBA)
§ Transcription Medicated Amplification (TMA)
§ Single Primer Isothermal Amplification (SPIA)
§ Loop-mediated Isothermal Amplification (LAMP)
§ By Application:
§ Infectious Disease Diagnostics
§ Blood Screening
§ Others
§ By End User:
§ Academic and Research Institutes
§ Diagnostic Laboratories
§ Others
§ By Country:
§ S.
§ Canada
o Europe
§ By Product Type:
§ Instruments
§ Reagents & Kits
§ By Technology:
§ Helicase Dependent Amplification (HAD)
§ Nicking Enzyme Amplification Reaction (NEAR)
§ Nucleic Acid Sequence Based Amplification (NASBA)
§ Transcription Medicated Amplification (TMA)
§ Single Primer Isothermal Amplification (SPIA)
§ Loop-mediated Isothermal Amplification (LAMP)
§ By Application:
§ Infectious Disease Diagnostics
§ Blood Screening
§ Others
§ By End User:
§ Academic and Research Institutes
§ Diagnostic Laboratories
§ Others
§ By Country:
§ U.K.
§ Germany
§ Italy
§ Spain
§ France
§ Russia
§ Rest of Europe
o Asia Pacific
§ By Product Type:
§ Instruments
§ Reagents & Kits
§ By Technology
§ Helicase Dependent Amplification (HAD)
§ Nicking Enzyme Amplification Reaction (NEAR)
§ Nucleic Acid Sequence Based Amplification (NASBA)
§ Transcription Medicated Amplification (TMA)
§ Single Primer Isothermal Amplification (SPIA)
§ Loop-mediated Isothermal Amplification (LAMP)
§ By Application:
§ Infectious Disease Diagnostics
§ Blood Screening
§ Others
§ By End User:
§ Academic and Research Institutes
§ Diagnostic Laboratories
§ Others
§ By Country:
§ Australia
§ India
§ China
§ Japan
§ ASEAN
§ South Korea
§ Rest of Asia Pacific
o Latin America
§ By Product Type:
§ Instruments
§ Reagents & Kits
§ By Technology:
§ Helicase Dependent Amplification (HAD)
§ Nicking Enzyme Amplification Reaction (NEAR)
§ Nucleic Acid Sequence Based Amplification (NASBA)
§ Transcription Medicated Amplification (TMA)
§ Single Primer Isothermal Amplification (SPIA)
§ Loop-mediated Isothermal Amplification (LAMP)
§ By Application:
§ Infectious Disease Diagnostics
§ Blood Screening
§ Others
§ By End User:
§ Academic and Research Institutes
§ Diagnostic Laboratories
§ Others
§ By Country:
§ Brazil
§ Mexico
§ Argentina
§ Rest of Latin America
o Middle East
§ By Product Type:
§ Instruments
§ Reagents & Kits
§ By Technology:
§ Helicase Dependent Amplification (HAD)
§ Nicking Enzyme Amplification Reaction (NEAR)
§ Nucleic Acid Sequence Based Amplification (NASBA)
§ Transcription Medicated Amplification (TMA)
§ Single Primer Isothermal Amplification (SPIA)
§ Loop-mediated Isothermal Amplification (LAMP)
§ By Application:
§ Infectious Disease Diagnostics
§ Blood Screening
§ Others
§ By End User:
§ Academic and Research Institutes
§ Diagnostic Laboratories
§ Others
§ By Country:
§ GCC Countries
§ Israel
§ Rest of Middle East
o Africa
§ By Product Type:
§ Instruments
§ Reagents & Kits
§ By Technology:
§ Helicase Dependent Amplification (HAD)
§ Nicking Enzyme Amplification Reaction (NEAR)
§ Nucleic Acid Sequence Based Amplification (NASBA)
§ Transcription Medicated Amplification (TMA)
§ Single Primer Isothermal Amplification (SPIA)
§ Loop-mediated Isothermal Amplification (LAMP)
§ By Application:
§ Infectious Disease Diagnostics
§ Blood Screening
§ Others
§ By End User:
§ Academic and Research Institutes
§ Diagnostic Laboratories
§ Others
§ By Country/Region:
§ South Africa
§ Central Africa
§ North Africa
· Company Profiles
o Alere Inc.,*
§ Company Overview
§ Product Portfolio
§ Financial Performance
§ Recent Highlights
§ Strategies
o Becton, Dickinson & Company
o BioHelix Corporation
o BioMerieux Biotechnology Company
o Hologic Gene-Probe
o QIAGEN Company
o Thermo Fisher Scientific, Inc.
o Lucigen Corporation
o Quidel Corporation
o NuGEN
“*” marked represents similar segmentation in other categories in the respective section.
https://www.coherentmarketinsights.com/insight/request-sample/2831
https://www.coherentmarketinsights.com/insight/request-pdf/2831
Click here to buy:https://www.coherentmarketinsights.com/insight/buy-now/2831
CMI Services:https://www.coherentmarketinsights.com/services
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.
What we provide:
· Customized Market Research Services
· Industry Analysis Services
· Business Consulting Services
· Market Intelligence Services
· Long term Engagement Model
· Country Specific Analysis
Mr. Shah
Coherent Market Insights Pvt. Ltd.
Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.
Phone: +1-206-701-6702
Email :[email protected]
Reference/Source: https://www.coherentmarketinsights.com/market-insight/isothermal-nucleic-acid-amplification-technology-inaat-market-2831